ArticleThe Journal of clinical investigation2019

Cyclin-dependent kinase inhibitor 2B regulates efferocytosis and atherosclerosis.

Yoko Kojima et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.